What is Femasys Inc (FEMY) stock price today?

Femasys Inc (FEMY) currently trades at $0.37 per share. The stock has a market capitalization of $24.58M and a P/E ratio of —x.

Is FEMY stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Femasys Inc has a Smart Value Score of 25/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is Femasys Inc's revenue and earnings?

Femasys Inc has trailing twelve-month (TTM) revenue of $2.29M with profit margins of 0.00%. Earnings per share (EPS) is $-0.47.

Is FEMY stock overvalued or undervalued?

Based on our DCF model, Femasys Inc's intrinsic value is $1.34, representing a margin of safety of 62.34%. The stock currently trades at a P/E of —x.

FEMY

Femasys Inc

NASDAQ: FEMY · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES

$0.37

-2.06% today

Updated 2026-04-30

Market cap

$24.58M

P/E ratio

—

P/S ratio

10.72x

EPS (TTM)

$-0.47

Dividend yield

—

52W range

$0 – $1

Volume

0.5M

Market cap

$24.58M

P/E ratio

—

P/S ratio

10.72x

EPS (TTM)

$-0.47

Dividend yield

—

52W range

$0 – $1

Volume

0.5M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.5

Profitability

6.7

Valuation

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →202 stocks currently score above 75

Price targets

Analyst target

$3.67

+904.11%

12-Month target

—

Intrinsic (DCF)

$1.34

Margin of safety

+62.34%

2 Strong Buy1 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 39.90% QoQ

+ 62.34% below intrinsic value

Risks

- Thin margins at 0.00%

- Negative free cash flow $-4.42M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$1.21M	$1.07M	$1.63M	$2.29M	$2.29M
Net income	$-11.39M	$-14.25M	$-18.82M	$-18.63M	$-3.95M
EPS	—	—	—	—	$-0.47
Free cash flow	$-11.14M	$-11.42M	$-20.21M	$-19.22M	$-4.42M
Profit margin	-944.62%	-1,329.06%	-1,155.03%	-812.27%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FEMY	$24.58M	25	8.0	2.5	6.7	5.0	+62.34%	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Femasys Inc trades at $0.37. Our Smart Value Score of 25/100 indicates the stock is weak. TTM revenue stands at $2.29M. Our DCF model estimates intrinsic value at $1.34.

Frequently asked questions

What is Femasys Inc's stock price?

Femasys Inc (FEMY) trades at $0.37.

Is Femasys Inc overvalued?

Smart Value Score 25/100 (Grade F, Strong Sell). DCF value $1.34.

What is the price target of Femasys Inc (FEMY)?

The analyst target price is $3.67, representing +904.1% upside from the current price of $0.37.

What is the intrinsic value of Femasys Inc (FEMY)?

Based on our DCF model, intrinsic value is $1.34, a +62.3% margin of safety versus $0.37.

What is Femasys Inc's revenue?

TTM revenue is $2.29M.

Company info

SectorHEALTHCARE

IndustryMEDICAL INSTRUMENTS & SUPPLIES

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio10.72x

ROE-455.80%

Beta-2.28

50D MA$0.49

200D MA$0.63

Shares out0.06B

Float0.05B

Short ratio—

Avg volume0.5M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

FEMY vs LLY →FEMY vs JNJ →FEMY vs ABBV →Stock screener →